KCNJ16 encodes the inwardly rectifying potassium channel Kir5.1, which belongs to the broader family of potassium channels that regulate cellular excitability and potassium homeostasis. The protein is characterized by its tendency to allow potassium ions to flow more readily into cells than out of them, a property known as inward rectification .
Kir5.1 channels are widely expressed in various tissues, with particular abundance in:
Renal tubular cells, where they participate in potassium recycling and pH sensing
Brain tissue, where they contribute to neuronal excitability and pH regulation
Cardiovascular system, influencing cardiac electrophysiology
The functional significance of Kir5.1 lies in its ability to form heteromeric channels with other Kir family members, particularly Kir4.1 (KCNJ10) and Kir4.2 (KCNJ15) . These heteromeric channels exhibit distinct electrophysiological properties compared to homomeric channels and are essential for fine-tuning cellular responses to changes in potassium concentration and pH.
The phosphorylation of KCNJ16 at serine 416 represents a critical post-translational modification that modulates channel activity. This specific phosphorylation event has been implicated in regulating:
Channel gating kinetics
Membrane trafficking and surface expression
Protein-protein interactions
Response to changes in cellular pH
Research indicates that the phosphorylation state of S416 can significantly alter the electrophysiological properties of Kir5.1-containing channels, affecting their contribution to cellular potassium homeostasis and pH regulation . The Phospho-KCNJ16 (S416) Antibody enables precise detection of this phosphorylated form, allowing researchers to investigate the dynamic regulation of channel function under various physiological and pathological conditions.
The Phospho-KCNJ16 (S416) Antibody has been employed in diverse experimental approaches to study the regulation and function of Kir5.1 channels. Key applications include:
Western blotting represents one of the primary applications for this antibody. When used at dilutions of 1:500-1:2000, the antibody can detect the phosphorylated form of KCNJ16 in cell and tissue lysates. The expected molecular weight of KCNJ16 is approximately 47 kDa, although the observed band size may be around 55 kDa due to post-translational modifications .
The antibody has been validated for immunohistochemical analysis of formalin-fixed, paraffin-embedded tissues at dilutions of 1:100-1:300. This application allows for the localization of phosphorylated KCNJ16 within tissue sections, providing insights into its distribution in organs such as the brain and kidney .
For immunofluorescence applications, the antibody can be used at dilutions of 1:200-1:1000 to visualize the subcellular localization of phosphorylated KCNJ16 in cultured cells. This technique has been employed to study the membrane trafficking and intracellular distribution of the phosphorylated channel .
The antibody is also suitable for enzyme-linked immunosorbent assays (ELISA) at dilutions typically around 1:5000, providing a quantitative method for measuring phosphorylated KCNJ16 levels in biological samples .
Research utilizing the Phospho-KCNJ16 (S416) Antibody has contributed to our understanding of the diverse physiological roles of Kir5.1 channels. These roles span multiple organ systems and fundamental biological processes, as outlined below.
Kir5.1 channels are abundantly expressed in renal tubular cells, where they form heteromeric channels with Kir4.1 (KCNJ10). These channels participate in:
Potassium recycling for proper Na+,K+-ATPase function
Basolateral potassium conductance in distal tubular segments
pH sensing and regulation of acid-base balance
Modulation of transepithelial transport of electrolytes, solutes, and water
Studies using genetic models have demonstrated that disruption of KCNJ16 function leads to renal electrolyte mishandling, including hypokalemia (low blood potassium), metabolic acidosis, and salt wasting. These findings highlight the critical role of Kir5.1 in maintaining renal function and systemic electrolyte balance .
KCNJ16 has emerged as a key regulator of respiratory control mechanisms, particularly in response to changes in CO2 and pH. Research on KCNJ16 mutant rats has revealed:
Chronic metabolic acidosis accompanied by compensatory hyperventilation
Reduced ventilatory responses to hypercapnic acidosis (elevated CO2)
Diminished hypoxic ventilatory response, suggesting a role in O2 sensing
Essential contribution to both acute and chronic regulation of arterial pH
These findings position Kir5.1 channels as integral components of the respiratory chemoreflexes that maintain acid-base homeostasis through ventilatory adjustments.
In the central nervous system, Kir5.1 channels contribute to neuronal excitability and pH sensitivity. The phosphorylation state of S416 may influence these functions by modulating channel properties and neuronal responses to physiological stimuli . Immunohistochemical studies using the Phospho-KCNJ16 (S416) Antibody have helped elucidate the distribution and regulation of these channels in brain tissue.
The application of Phospho-KCNJ16 (S416) Antibody in research has facilitated investigations into the role of KCNJ16 in various pathological conditions. Recent studies have identified genetic mutations in KCNJ16 associated with several disease phenotypes.
Biallelic variants in KCNJ16 have been identified in patients with a novel disease phenotype characterized by:
Hypokalemic tubulopathy with renal salt wasting
Disturbed acid-base homeostasis
Functional studies demonstrated that these mutations significantly reduce currents when mutant KCNJ16 is coexpressed with KCNJ15 or KCNJ10, indicating impaired function of heteromeric potassium channels. This disruption affects both proximal tubular bicarbonate handling and distal tubular salt reabsorption, explaining the complex renal phenotype observed in affected individuals .
Studies in KCNJ16 mutant rodents have revealed significant respiratory and metabolic abnormalities, including:
Chronic metabolic acidosis partially compensated by hyperventilation
Reduced ventilatory responses to hypercapnia and hypoxia
Dysregulation of acid-base balance
These findings suggest potential implications for human respiratory and metabolic disorders, although further research is needed to establish direct clinical correlations.
Mutations in KCNJ16 have been identified in patients with nonfamilial Brugada syndrome, characterized by cardiac arrhythmias and sudden death . The phosphorylation state of KCNJ16 at S416 may influence the electrophysiological properties of cardiac tissue, potentially contributing to arrhythmogenesis in susceptible individuals.
Researchers have developed various experimental approaches utilizing the Phospho-KCNJ16 (S416) Antibody to investigate the regulation and function of KCNJ16. These methods provide valuable insights into the phosphorylation-dependent aspects of channel behavior.
Western blotting with the Phospho-KCNJ16 (S416) Antibody allows researchers to monitor changes in the phosphorylation status of KCNJ16 in response to various stimuli, including:
pH changes and acid-base disturbances
Electrolyte imbalances, particularly alterations in potassium levels
Pharmacological agents targeting signaling pathways
Physiological stressors such as hypoxia or hypercapnia
This approach has been instrumental in elucidating the signaling mechanisms regulating KCNJ16 phosphorylation and their functional consequences .
Immunohistochemistry and immunofluorescence techniques employing the Phospho-KCNJ16 (S416) Antibody have revealed:
Tissue-specific expression patterns of phosphorylated KCNJ16
Subcellular localization in polarized epithelial cells
Colocalization with interacting proteins, particularly other Kir family members
Redistribution in response to physiological stimuli or pathological conditions
These studies have enhanced our understanding of how phosphorylation influences the localization and membrane trafficking of KCNJ16 .
Combining electrophysiological recordings with immunological detection of phosphorylated KCNJ16 has allowed researchers to correlate phosphorylation status with channel function. Such approaches have demonstrated that:
Phosphorylation at S416 can alter channel gating properties
The effects of phosphorylation depend on heteromeric assembly with other Kir subunits
Physiological stimuli that induce phosphorylation can modify channel activity
Pathological conditions may disrupt normal phosphorylation-dependent regulation
The Phospho-KCNJ16 (S416) Antibody continues to be a valuable tool for ongoing and future research into the regulation and function of Kir5.1 channels. Several promising research directions include:
Understanding the regulation of KCNJ16 phosphorylation may reveal novel therapeutic targets for conditions associated with channel dysfunction. The antibody could play a crucial role in screening potential modulators of phosphorylation and evaluating their effects on channel function.
The identification of KCNJ16 mutations in specific disease phenotypes warrants broader genetic screening in diverse patient populations. The antibody could be instrumental in characterizing the functional consequences of newly identified variants, particularly their effects on S416 phosphorylation.
Combining the antibody with super-resolution microscopy or other advanced imaging approaches could provide unprecedented insights into the spatial organization and dynamics of phosphorylated KCNJ16 in native tissues and cellular models.
What is KCNJ16/KIR5.1 and why is the phosphorylation at S416 significant?
KCNJ16, also known as KIR5.1, is an inward-rectifying potassium channel subunit that forms functional heteromeric channels with Kir4.1 (encoded by KCNJ10) or Kir4.2 (encoded by KCNJ15). These channels are widely expressed in kidneys, pancreas, thyroid, brain, and other organs . While KIR5.1 typically cannot form functional homomeric channels in most cases, it plays crucial roles in multiple physiological processes, particularly in pH sensing and potassium homeostasis .
The S416 site is a key phosphorylation site that appears to regulate channel function. Based on experimental evidence, phosphorylation at this residue likely modulates channel activity as part of PKA-mediated signaling pathways . This post-translational modification may alter channel gating properties, membrane trafficking, or interaction with regulatory proteins.
In which tissues is KCNJ16 expression most significant for research?
KCNJ16 demonstrates tissue-specific expression patterns that are particularly relevant for researchers studying:
Kidney: Expressed in both proximal and distal tubules, where it plays critical roles in potassium sensing and acid-base homeostasis
Brain: Forms functional channels with PSD-95 in neurons, potentially regulating synaptic transmission
Understanding the tissue-specific expression is essential when designing experiments to investigate KCNJ16 function in physiological and pathological conditions.
What are the key applications for Phospho-KCNJ16 (S416) antibodies?
Phospho-KCNJ16 (S416) antibodies are validated for multiple experimental applications:
| Application | Recommended Dilution | Key Considerations |
|---|---|---|
| Western Blot (WB) | 1:500-1:2000 | Expected band size: ~48 kDa |
| Immunohistochemistry (IHC) | 1:100-1:300 | Paraffin-embedded sections |
| Immunofluorescence (IF) | 1:200-1:1000 | Cell fixation with paraformaldehyde |
| ELISA | 1:5000 | Phosphopeptide specific |
These applications enable researchers to detect phosphorylated KCNJ16 in various experimental settings, allowing for comprehensive analysis of channel regulation and function .
What are the most common issues when working with Phospho-KCNJ16 (S416) antibodies and how can they be resolved?
Researchers often encounter these challenges when working with phospho-specific antibodies:
| Problem | Possible Causes | Solutions |
|---|---|---|
| Weak or no signal | Phosphorylation lost during sample preparation | Include phosphatase inhibitors in all buffers |
| Insufficient antibody concentration | Optimize antibody dilution (start with 1:500 for WB) | |
| Low phosphorylation state in basal conditions | Stimulate cells with forskolin (40nM, 30 min) to increase phosphorylation | |
| Non-specific bands | Cross-reactivity | Use blocking peptide controls to identify specific signal |
| Secondary antibody issues | Include secondary-only controls | |
| Variability between experiments | Phosphorylation state fluctuations | Standardize sample collection and handling procedures |
| Antibody degradation | Aliquot antibody to avoid freeze-thaw cycles |
For optimal results, store the antibody at -20°C for long-term storage and at 4°C for frequent, short-term use within one month .
How can I optimize immunohistochemistry protocols for Phospho-KCNJ16 (S416) detection in tissue sections?
For successful immunohistochemical detection of phosphorylated KCNJ16:
Tissue fixation: Use 4% paraformaldehyde; overfixation can mask epitopes
Antigen retrieval: Heat-induced epitope retrieval in citrate buffer (pH 6.0) often works best for phospho-epitopes
Blocking: Use 5-10% normal serum from the same species as the secondary antibody
Primary antibody: Start with 1:100 dilution and optimize; incubate overnight at 4°C
Controls: Include phosphopeptide-blocked controls as shown in validation images
Signal amplification: Consider tyramide signal amplification for low-abundance phospho-proteins
Counterstaining: Use DAPI for nuclear visualization; avoid hematoxylin if it interferes with signal detection
Brain tissue sections have been successfully stained using these approaches, as demonstrated in validation studies .